Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

The three-year UNITED 2.0 initiative will use advanced DNA testing and AI to give doctors a more complete picture of a patient’s cancer and help match treatments more precisely.

This biological process, where mature, specialized cells lose their distinct characteristics and revert to a more primitive, aggressive state, is a universally recognized sign of poor prognosis across ...

The team will adopt a dual WES-WTS approach for more detailed tumour profiling. Lucence, Diagnostics Development Hub hosted ...

Researchers identify five specific neuron subgroups in the motor cortex most vulnerable to TDP-43 protein clumps in ALS and Frontotemporal Dementia.

Single-cell RNA sequencing of endometrial samples across the menstrual cycle identified key cell types and gene signatures ...

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

Researchers found a grin2a mutation disrupts a brain circuit that updates beliefs using new information. In mice, restoring ...

Researchers built an open tool to handle complex genome sequencing data, offering automated quality control, improved variant ...

Genome and epigenome editors—including CRISPR nucleases, base editors, prime editors, and emerging RNA/epitranscriptomic editors—are advancing rapidly, but ...